Biogen (BIIB) PT Lowered to $221 at Mizuho
Get Alerts BIIB Hot Sheet
Price: $219.24 +3.15%
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 13
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 13
Join SI Premium – FREE
Mizuho analyst Salim Syed lowered the price target on Biogen (NASDAQ: BIIB) to $221.00 (from $236.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Baidu (BIDU) PT Lowered to $150 at Benchmark on Near-Term Margin Concerns
- Morgan Stanley Downgrades Diamondback Energy (FANG) to Equalweight
- BofA Securities Upgrades Moderna (MRNA) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share